SARS-CoV-2 variant Omicron:currently the most complete“escapee”from neutralization by antibodies and vaccines  

作　　者：Maochen Li Fuxing Lou Huahao Fan 

机构地区：[1]College of Life Science and Technology,Beijing University of Chemical Technology,100029,Beijing,China

出　　处：《Signal Transduction and Targeted Therapy》2022年第2期343-345,共3页信号转导与靶向治疗（英文）

基　　金：This research was supported by National Key Research and Development Program of China(grant no.2019YFC1200502,2020YFA0712102,BWS21J025,20SWAQK22);National Natural Science Foundation of China(grant no.82151224);Fundamental Research Funds for Central Universities(grant no.BUCTZY2022);H&H Global Research and Technology Center(grant no.H2021028).

摘　　要：On December 23,2021,five groups published their research results of clinical-approved monoclonal antibodies,convalescent serum,and vaccine serum against B.1.1.529(Omicron)on Nature.1–5 As a SARS-CoV-2 variant of concern(VOC),variant Omicron named by World Health Organization(WHO)with more mutations possesses the increased immune escape ability than all previous reported circulating variants,which has attracted extensive attention all over the world(Fig.1a).

关 键 词：ANTIBODIES vaccine vaccines 

分 类 号：R73[医药卫生—肿瘤]